Published in

BioMed Central, BMC Pharmacology and Toxicology, 1(15), 2014

DOI: 10.1186/2050-6511-15-55

Links

Tools

Export citation

Search in Google Scholar

Open, single-blind, double-blind: which peer review process do you prefer?

Journal article published in 2014 by Ciaran O. Neill, Elizabeth C. Moylan ORCID, Simon Harold, Ciaran O'Neill ORCID, Maria K. Kowalczuk ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Abstract BMC Pharmacology and Toxicology was created from the merger of two journals within the BMC series published by BioMed Central: BMC Pharmacology and BMC Clinical Pharmacology. BMC Pharmacology operated anonymous peer review whereas BMC Clinical Pharmacology operated a fully open peer review policy where the identity of the reviewers was known to the editors, authors and readers. The merged journal also adopted a fully open peer review policy. Two years on we discuss the views and experiences of our Editorial Board Members towards open peer review on this biomedical journal.